BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1971229)

  • 1. Solar urticaria in the visible spectrum successfully treated with astemizole.
    Monfrecola G; Nappa P; Pini D
    Dermatologica; 1990; 180(3):154-6. PubMed ID: 1971229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].
    Kurz K
    Z Hautkr; 1986 Nov; 61(22):1646-53. PubMed ID: 2880431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic urticaria with a new synthetic antihistamine: astemizole].
    Annunziata M; Aimo Boot D
    G Ital Dermatol Venereol; 1984; 119(5):XVII-XX. PubMed ID: 6150894
    [No Abstract]   [Full Text] [Related]  

  • 4. Astemizole--another non-sedating antihistamine.
    Med Lett Drugs Ther; 1989 May; 31(791):43-4. PubMed ID: 2565524
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
    Paul E; Bödeker RH
    Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic idiopathic urticaria with astemizole.
    Huerter CJ; Bergfeld WF; Wagner WO; Dijkstra JW
    Cleve Clin J Med; 1989 May; 56(3):263-6. PubMed ID: 2568189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Astemizole in urticaria--a multicenter study by 412 established dermatologists].
    Kurz K; Oestreich W
    Z Hautkr; 1987 Dec; 62(24):1724-32. PubMed ID: 2894098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [General review of a non-sedative antihistaminic, astemizole (Hismanal), a H1 receptor antagonist].
    Molkhou P
    Allerg Immunol (Paris); 1988 May; 20(5):197-201. PubMed ID: 2900641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole.
    Honsinger RW; Thomsen RJ
    Ann Allergy; 1990 Sep; 65(3):194-200. PubMed ID: 1976298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H1-receptor-active histamine not sole cause of chronic idiopathic urticaria.
    Krause LB; Shuster S
    Lancet; 1984 Oct; 2(8408):929-30. PubMed ID: 6148648
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
    Paul E; Bödeker RH
    Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of histamine-induced conjunctivitis by the oral antihistamine, astemizole.
    Stokes TC; Feinberg G
    Br J Clin Pharmacol; 1988 Jun; 25(6):771-3. PubMed ID: 2904824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astemizole-associated urinary retention.
    Lin AY; Zahtz G; Myssiorek D
    Otolaryngol Head Neck Surg; 1991 Jun; 104(6):893-4. PubMed ID: 1679231
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical profile of astemizole. A survey of 50 double-blind trials.
    Vanden Bussche G; Emanuel MB; Rombaut N
    Ann Allergy; 1987 Mar; 58(3):184-8. PubMed ID: 2881507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
    Soter NA
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema.
    Kailasam V; Mathews KP
    J Am Acad Dermatol; 1987 Apr; 16(4):797-804. PubMed ID: 2883202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihistamines in the treatment of urticarial disorders.
    Shuster S
    Cutis; 1988 Oct; 42(4A):26-8. PubMed ID: 2903816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a new antihistamine: astemizole.
    Ray JA
    N Engl Reg Allergy Proc; 1985; 6(1):71-7. PubMed ID: 2888010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal effect of complete H1 receptor blockade on urticaria pigmentosa.
    Krause LB; Shuster S
    Acta Derm Venereol; 1985; 65(4):338-40. PubMed ID: 2413691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilastine: a new H
    Church MK; Labeaga L
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1447-1452. PubMed ID: 28467671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.